IVTEAM
CLABSI in totally implantable venous-access ports – Full Text
"Here we report an analysis of CLABSI risk factors in patients with CV ports at our institution" Ishikawa et al (2025).
Do you have news you would like to share on the NIVAS News Hub?
If you have an RSS feed you wish to share with up please contact us here.
Showing 1117-1128 of 1905 results.
"Here we report an analysis of CLABSI risk factors in patients with CV ports at our institution" Ishikawa et al (2025).
"To determine the accuracy measures of clinical indicators of Nursing Diagnosis (ND) of the International Classification of Nursing Practice (ICNP)®, Adverse Location of Peripherally Inserted Central Catheter in a Neonatal Intensive Care Unit (NICU)" Prado et al (2025).
"TOptimising discharge instructions and patient education strategies for these factors may improve patients' readiness for discharge, reduce the risk of PICC-related complications, and improve outcomes" Pan et al (2025).
"With the rise of antibiotic resistance and the emergence of multidrug-resistant organisms (MDROs), there is a growing concern about the relationship between MDROs and CRBSI" Li et al (2025).
"In this study, we investigated which venodilatation method is most appropriate for hypotensive patients, a group in whom vascular access is predicted to be difficult" Şirin et al (2025).
"Whole guidewire retention occurs in 1:3167 procedures. While training and current policies prevent most whole guidewire retentions, they do not stop the error from occurring and rely on removing human error consistently across thousands of procedures to prevent a single event. A safety-engineered mechanism of error prevention is required that applies to any clinical environment, is impervious to distraction or interruption, and does not rely on clinician memory to ensure guidewire removal" Mariyaselvam et al (2025).
"The use of vascular ports in oncology patients for the administration of irritating and chemotherapeutic drugs clearly solves the problem of peripheral vascular damage caused by oncological drugs, and at the same time provides a comfortable way of treating patients in the long term" Olszewska et al (2025).
"We aimed to characterize the appropriateness of peripherally inserted central catheters (PICCs) in hospitalized infants and to explore the feasibility of a randomized clinical trial (RCT) of antiplatelet therapy to prevent CRT in these infants" Chegondi et al (2025).
"Pediatric intravascular CVC length can be estimated by formulas suggested by the present study based on the insertion side and patient height, limiting x-ray exposure during CVC insertion and decreasing potential complications" Zaghloul et al (2025).
"This manuscript examines the use of respiratory therapists (RTs) to perform central venous and arterial line placements to address the lack of available staff to perform these procedures" McClay et al (2025).
"The incidence of CPK elevation was similar previously reported rates. This expands the literature to patients with daptomycin doses>6 mg/kg and prolonged durations of therapy. The incidence of CPK elevation and time to onset of 9-16 days supports the current recommendations for weekly lab monitoring" Wiley et al (2025).
"This report describes a case of inadvertent subclavian artery catheterization that was successfully managed with the ExoSeal vascular closure device" Wang et al (2025).
